oh they were active as all get out on PTOI back in the day

New Post Public Reply Private Reply Replies (0) Message Board
4kids AlanC #40981
342
oh they were active as all get out on PTOI back in the day of the *aromatics*

birds of a feather

no surprise there ..

4kids

How many of CANT''s Reg SHO violations were trades of PTOI I wonder? GO PTOI!!!

For Release: Tuesday, March 5, 2019 Contact(s):
Michelle Ong (202) 728-8464
Mike Rote (202) 728-6912

FINRA Fines Cantor Fitzgerald $2 Million for Regulation SHO Violations and Supervisory Failures
Firm Required to Retain an Independent Consultant

WASHINGTON – FINRA announced today that it has fined Cantor Fitzgerald & Co. (Cantor) $2 million for Regulation SHO (Reg SHO) violations and supervisory failures spanning a period of at least five years. As part of the settlement, Cantor also agreed to retain an independent consultant to conduct a comprehensive review of the firm’s policies, systems, procedures and training related to Reg SHO.
The Securities and Exchange Commission adopted Reg SHO to address concerns regarding persistent failures to deliver and potentially abusive “naked” short selling, e.g., the sale of securities that an investor does not own or has not borrowed. The rule requires firms to deliver the shares on settlement date or take affirmative action to close out the “failure to deliver” shares by purchasing or borrowing the securities. If the failure to deliver is not closed out, the firm may not accept additional short sale orders in the security without first borrowing or arranging to borrow the security.
FINRA found that, from January 2013 through December 2017, Cantor’s supervisory system, including its written supervisory procedures (WSPs), was not reasonably designed to achieve compliance with the requirements of Reg SHO. Cantor’s use of a predominantly manual system to supervise its compliance with Reg SHO was not reasonable in light of the firm’s business expansion and increased trading activity - from 35 billion shares in 2013 to 79 billion shares in 2014. Also, Cantor’s compliance personnel identified red flags in 2013, 2014 and 2015 indicating that the firm had systemic issues with Reg SHO and that its supervisory systems were not reasonably tailored to its business. While Cantor made some changes, it did not adapt and enhance its supervision to address the deficiencies its personnel identified, commit additional staffing to monitoring its compliance with Reg SHO, or implement WSPs relating to its new lines of business until 2016. Moreover, Cantor’s enhancements to its supervisory systems and procedures were not fully effective. For example, Cantor failed to identify fails-to-deliver in accounts that were not monitored by its supervisory systems.
FINRA also found that Cantor failed to timely remediate issues identified by its personnel. This was not reasonable considering, among other things, the firm’s prior disciplinary history relating to Reg SHO. As a result, Cantor did not timely close-out at least 4,879 fails-to-deliver, and routed and/or executed thousands of short orders in those securities without first borrowing (or arranging to borrow) the security or issuing notice of the need for a pre-borrow to the broker-dealers for whom it cleared and settled trades.
“Firms need to ensure that their supervisory systems are reasonably tailored to their business and once they become aware of deficiencies in their supervisory systems, they must promptly remediate them,” said Susan Schroeder, FINRA Executive Vice President, Department of Enforcement. “As our Annual Examination Priorities letters make clear, firms’ compliance with Regulation SHO is a continued focus for FINRA when evaluating operational risk and is necessary to preserve investor confidence.”
In determining the sanctions imposed, FINRA considered Cantor’s prior disciplinary history relating to Reg SHO, that the misconduct occurred over approximately a five-year period, the firm’s failure to address red flags in a timely manner, the continuing supervision deficiencies, as well as the firm’s efforts to improve its supervisory systems. In settling this matter, Cantor neither admitted nor denied the charges, but consented to the entry of FINRA’s findings.
About FINRA
FINRA is a not-for-profit organization dedicated to investor protection and market integrity. It regulates one critical part of the securities industry – brokerage firms doing business with the public in the United States. FINRA, overseen by the SEC, writes rules, examines for and enforces compliance with FINRA rules and federal securities laws, registers broker-dealer personnel and offers them education and training, and informs the investing public. In addition, FINRA provides surveillance and other regulatory services for equities and options markets, as well as trade reporting and other industry utilities. FINRA also administers a dispute resolution forum for investors and brokerage firms and their registered employees. For more information, visit www.finra.org.



www.finra.org/newsroom/2019/finra-fines-cantor-fitzgerald-2-million-regulation-sho-violations-and-supervisory

Plastic2Oil, Inc. (PTOI) Stock Research Links

PTOI Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Navigating the Nitty-Gritty of Cabin Rental Management

Updated Category News Views 10

The Real Elbow Grease Behind Cabin Management Ever imagined what it’d take to keep a vacation rental cabin running like a tight ship? Well, Nathan Fitts breaks it down real clear-like. The guy's seen it all in Blue Ridge, Georgia, which isn't just about scenic views—there's serious business brewing behind that cabin charm. More Than Just Fluffing Pillows Turns out,...

Continue Reading
D2L Ventures into Vietnam with Van Lang Alliance

Updated Category News Views 16

Unlocking New Frontiers in Vietnam's Education Well, looks like D2L is rolling into Vietnam with the kind of gusto you'd expect from a company that fancies itself a trailblazer in learning tech. This ain't just another humdrum expansion story; it's a five-year handshake with Van Lang Education Group that's got the tech firm dropping its anchor in a fresh and promising...

Continue Reading
Navigating AI Laws: A New Era for Privacy & Security

Updated Category News Views 16

Crucial Insights from the Convergence Conference Rich with intrigue, the privacy and AI governance game just upped its stakes. If there ever was a time to listen closely, it's now, people. With over 150 laws sprouting up faster than weeds, businesses are getting squeezed to keep their artificial ducks in a row. Last month over in New York, some big names in law and...

Continue Reading
First Student Reduces Collisions by 63% with HALO Tech

Updated Category News Views 13

Making Every School Bus Ride Safer Here's some good news in the world of transportation, especially if you're keen on keeping kids safe on the daily school bus run. First Student's HALO™ Connected Transportation Platform claims it made a significant dent in reducing accidents—specifically, a 63% cut in forward collision risk. It's a big promise when you're talking...

Continue Reading
Alaska LNG Project Boosted by Strategic Positioning

Updated Category News Views 10

Alaska LNG: Right Place, Right Time Someone bring out the confetti, because Paul Sullivan, Co-Chairman of Gastech, is celebrating Alaska LNG like it's 1999. And for good reason. If Alaska ever played its cards right, now's the moment according to the industry veteran. After Gastech 2026 wrapped its events in Bangkok last month, Sullivan laid out why the stars are aligning...

Continue Reading
DOCS Faces Investor Legal Battle for Alleged Misconduct

Updated Category News Views 11

The DOCS Predicament: Investors Facing Class Action Doximity, Inc., trading as NYSE:DOCS, finds itself in hot water again as shareholders gear up for a legal skirmish over alleged securities fraud. Schall, Brown & Schwartz LLP, the firm rallying the shareholders, has fired the opening salvo, pointing fingers at Doximity for cooking the books about their Newsfeed’s...

Continue Reading
INSPIRE 2026: Luxury Hotel Trends and Investments

Updated Category News Views 5

Luxury Hotels: Where's the Money Headed? All eyes on Orlando this December 15–16, where the International Luxury Hotel Association (ILHA) is calling the shots. INSPIRE 2026 is the marquee event of the year for luxury hospitality, and it ain't just about starry chandeliers and velvet drapes. We're talking real capital shifts, margins pinching tighter, and a future...

Continue Reading
eGlint's Rapid Tech Revolutionizes Proteomics with Win

Updated Category News Views 6

A Game-Changer in Proteomics Now ain't this something—eGlint just scooped up the 2026 BioTools Innovator Grand Prize, waving a big ol' $250,000 check around and claiming the biotech spotlight with their swift-moving ProteoNex™ platform. Forget about sticking samples through sluggish labs and waiting an eternity; eGlint's tech is flipping the switch, serving up protein...

Continue Reading
OppFi Readies Q3 Earnings; Investors Eye Financials

Updated Category News Views 8

What's Unfolding at OppFi? Mark your calendars, folks. October 28th is the day OppFi (NYSE: OPFI) pulls the curtain back on its third-quarter 2026 earnings. For the uninitiated, we're talking about a tech-driven finance platform that's been making waves by providing financial solutions for everyday Americans. And you bet we're all ears for what those numbers say. Details...

Continue Reading
Senté’s Heparan Sulfate Pairing: Peer-Reviewed Success

Updated Category News Views 8

Senté's Science-Driven Approach in Skincare Alright, cutting through the skincare noise, Senté Labs has pulled off something impressive—not just another jar of promises but actual, peer-reviewed science backing their Defense C Serum. Published in the Journal of Cosmetic Dermatology, this study isn't just talk about ingredients; it's a show of real results. This isn't...

Continue Reading

Top 5 Most Recently Viewed Articles

Ontex's Q3 Results Show Strong Progress Despite Market Challenges

Updated Category News Views 143

Ontex's Financial Performance for Q3 Ontex has released its latest financial results, revealing a noteworthy overall performance in the third quarter. Despite facing some challenges in consumer demand, the company reported a revenue of €445 million, marking a 3.8% year-on-year decrease when compared to comparable periods. However, when assessed against the previous...

Continue Reading
Youth Financial Independence: The Case for 16-Year-Old ISAs

Updated Category News Views 145

Empowering Youth to Manage Their Finances The conversation around financial independence for the younger generation is gaining traction. A recent campaign is advocating that the Government lowers the age for opening Individual Savings Accounts (ISAs) to 16 years old. This proposal aligns with various rights already held by young people, such as leaving school, working...

Continue Reading
Gantry Achieves Milestone with $20 Billion Loan Servicing Growth

Updated Category News Views 104

Gantry Sees Significant Increase in Q3 Loan Production Gantry, known as the largest independent commercial mortgage banking firm in the U.S., has reported impressive growth in new commercial mortgage production for the third quarter. The quarter saw a notable increase of nearly 10% over the totals from both the previous two quarters. This positive trend is bolstered by...

Continue Reading
Icahn Enterprises L.P. to Host Q3 2025 Earnings Call Discussion

Updated Category News Views 144

Upcoming Earnings Conference Call for Icahn Enterprises L.P. Icahn Enterprises L.P. (NASDAQ: IEP) has exciting news to share regarding its upcoming Q3 2025 earnings conference call. This important event will take place on a webcast, scheduled for Wednesday, November 5, 2025, at 10:00 a.m. Eastern Time. Investors and interested parties are encouraged to tune in to hear the...

Continue Reading
Iovance Biotherapeutics Announces Conference Presentations in 2025

Updated Category News Views 697

Iovance Biotherapeutics Announces Upcoming Conference Appearances Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a pioneering biotechnology firm dedicated to advancing treatments through innovative polyclonal tumor infiltrating lymphocyte (TIL) therapies, has revealed that its senior executive team will be showcasing their expertise at several prestigious conferences in...

Continue Reading